SELLAS Life Sciences Group(DE:RXK3)
€7.46-0.04 (-0.53%)
DE:RXK3
SELLAS Life Sciences Group earnings date
€7.46
At close:-0.04 (-0.53%)
SELLAS Life Sciences Group (RXK3) Q3 2018 Earnings Report
2 Followers
DE:RXK3 Q3 2018 EPS Results
- Actual EPS
- -EUR 24.04
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 204.11
DE:RXK3 Q3 2018 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2018
- Date
- 11/15/2018
- Time
- TBA
- Conference Call
- Thursday, November 15, 2018
DE:RXK3 Upcoming Earnings
SELLAS Life Sciences Group's next earnings date is estimated for March 25, 2027, based on past reporting schedules.
Q3 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:RXK3 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 25, 2027 | 2026 (Q4) | -0.05- | -0.05 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.05-0.05 | -0.05 | 16.67% (+0.01) | |
| Aug 11, 2026 | 2026 (Q2) | -0.04-0.05 | -0.06 | 28.57% (+0.02) | |
| May 12, 2026 | 2026 (Q1) | -0.05-0.05 | -0.06 | 28.57% (+0.02) | |
| Mar 19, 2026 | 2025 (Q4) | -0.06-0.05 | -0.05 | 16.67% (+0.01) | |
| Nov 12, 2025 | 2025 (Q3) | -0.07-0.05 | -0.09 | 40.00% (+0.04) | |
| Aug 12, 2025 | 2025 (Q2) | -0.07-0.06 | -0.12 | 46.15% (+0.05) | |
| May 13, 2025 | 2025 (Q1) | -0.10-0.06 | -0.19 | 66.67% (+0.13) | |
| Mar 20, 2025 | 2024 (Q4) | -0.10-0.05 | -0.21 | 73.91% (+0.15) | |
| Nov 13, 2024 | 2024 (Q3) | -0.12-0.09 | -0.3 | 69.70% (+0.21) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
